The UK’s National Measurement Institute recently launched the 3D OrbiSIMS, an innovative molecular imaging instrument developed with GSK which could help to determine drug failures earlier in the trial process. We investigate the potential of the instrument, which allows for the detection of drugs and metabolites with sub-cellular resolution, helping researchers determine the precise distribution of a medicine and the effect it has within a cell.

We also take a look at a new power system for medical devices developed by Cambridge Consultants which promises flexible, efficient and safe wireless power transfer to devices inside the body without precise alignment with the implant, and regardless of the size and body shape of the patient. Plus, we find out how companies can meet changing regulatory requirements affecting data management, such as the upcoming ISO IDMP standards and new FDA CMC guidance.

As always, we also round up the latest news from the medical device industry, and get comment and analysis from GlobalData’s healthcare analysts on market dynamics, product innovation, regional developments and regulatory issues.